• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: Featured Articles

Featured Articles

Emergency telemedicine

, 26 August 2020/in Featured Articles /by 3wmedia

Over recent decades, the field of telemedicine has been witness to periods of great promise, relative stasis as well as overstretch and false starts.
However, there is one telemedicine application which has seen steady, consistent growth. This is emergency telemedicine, where application development, especially teleconsultation and teleradiology, has synchronized with increasing demand for A&E as well as the forward march of telecoms technology.
From the outset, the benefits of telemedicine were self-evident in emergency care in settings such as ski resorts, highway or rail accidents, and after natural disasters. Telemedicine enabled trauma specialists to interact with overtaxed field personnel on site, to gauge the severity of injuries and provide clinical assessments on treatment or evacuation. This aspect of telemedicine was spun out off one of its first movers, the military.

Telemedicine and travel
The roots of ‘serious’ telemedicine practice can be considered to date to the 1990s. Nevertheless, medical practitioners were aware of the enormous possibilities it afforded well before this.
In the 1930s, luxury liners used marine radio-telephones to communicate with physicians about urgent cases on board. Travellers were again the core target market for the first teleradiology consultations, conducted in the 1960s by Dr. Kenneth Bird, who used a two-way/interactive television system that connected Massachusetts General Hospital to Boston’s Logan Airport to provide emergency medical care.
1994: A&E referrals fall at Belfast hospital
Among the earliest case studies on modern emergency telemedicine is a 12-month review of a 1994 link between the Royal Victoria Hospital in Belfast and a minor treatment centre (MTC) in South Westminster, London. Over the study period, the telemedicine link was actively used in only about 0.5% of cases. However, the number of patients referred to a GP fell dramatically as did those referred to A&E. Another interesting observation was an increase in confidence of the nursing staff at the Westminster MTC.
Wembley study compares outcomes, radiologists vs. teleradiologists
At the beginning of 1996, Wembley Community Hospital in London established a minor accident treatment service (MATS), supported by an advanced telemedical link to Central Middlesex Hospital. The system was run by emergency nurse practitioners based on a set of clinical protocols which consisted of prompts advising the use of telemedicine.
Two years later, a paper evaluated six months activity at the MATS, covering all patients seen – a total of 2,843, with 150 teleconsultations. After an interval of three months, 99 per cent of telemedical and 95 percent of non-telemedical cases were followed up. Interestingly, while no further problems had arisen with the telemedical group, 26 of the non-telemedicine group had consulted their GP for the same problem. Another interesting finding was that A&E teleconsultants interpreting radiographs performed better than the consultant radiologist who subsequently interpreted the original films.

Head CT scans

Similar efforts were also made in the US and continental Europe. Other than minor injuries support, another application area with near-universal acceptance in A&E practice consisted of the transmission of head CT scans to a tertiary neurosurgical centre, in order to obtain an immediate expert opinion.

Economic impact of emergency telemedicine

By the late 1990s, rather than convenience alone, the first arguments about the economic impact of emergency telemedicine had begun to appear. A 1997 paper from Hong Kong found a significant reduction in unnecessary transfers, alongside a decrease in adverse events occurring during transfer. Another study from Austria during the same year concluded that though teleradiology for CT scans was more expensive than transferring the physical scans by taxi, it was considerably quicker, and much less expensive than transferring the patient.

Growing ER costs drive US interest in telemedicine
The acceleration of growth in mobile telecoms quality onwards from the late 2000s, along with sharp falls in cost, has intensified the case for emergency telemedicine. Alongside, increased demographic pressure on emergency rooms due to an ageing population and ER staff shortfalls have strengthened this further.
ER figures have been used to make the case for emergency telemedicine in the US. 130 million people visit ERs each year, up 36 percent from 97 million in 1995. In spite of this, the number of ERs in the US dropped by 11 percent over the period.
One leading healthcare provider, Cardinal Health, estimates that the average costs of a telehealth visit at USD 40-50, compared to USD 922 for an emergency room visit and that telemedicine could eliminate nearly 1 in 5 ER visits, which corresponds in numbers to almost two-thirds of those discovered to be non-urgent. Cardinal Health also states that 20% of ER visits require follow-up care for similar conditions, while only 6% of telehealth visits do. This echoes the spirit of the findings of the Wembley Community Hospital MATS study in 1996, mentioned previously.

Waiting times and demographic pressures
The problems with emergency medical care are similar in Britain. A&E waiting times have increased substantially over recent years, with many National Health Service (NHS) units failing to meet a four-hour standard for admission and discharge at national level. The number of people going to A&E has also risen substantially. In 2016/17 there were 23.4 million attendances at A&E departments – the equivalent of 63,000 attendances each day on average, and since 2011/12, this has been growing by 1.7 per cent each year – or the equivalent of an extra 5,100 each day.
These pressures have been exacerbated by closures. One in six A&E departments are being closed or downgraded, which corresponds to 33 casualty departments in hospitals in 23 areas of the UK.

The scourge of unnecessary visits
Unnecessary visits to A&E account for 16% of the total in England, but go over 50% in areas such as Durham and Darlington. From time to time, the media has a field day, citing lists from health officials about people going to A&E with broken false nails, splinters in their fingers, emergency contraception, as well as shaving and paper cuts.
The situation is similar in the US, where over 30% of visitors discover their case is not urgent – after being attended to. Some studies have estimated that 14 to 27 percent of ER visits could be treated at facilities like retail clinics or urgent care centres, with potential savings of USD 4.4 billion.
Telehealth to ‘redesign’ emergency medicine ?
A 2017 study from the University of Warwick calls for using telehealth to “redesign” emergency medical services. It chooses best of breed cases from different continents to make three cases:
        • Specialists in underserved communities
        • Pre-ambulance triage
        • Ambulance-based triage

Providing patient access to remote specialists in underserved communities
In its early stages, emergency telemedicine applications were motivated by the need to provide more timely diagnosis and care to patients in underserved communities, in other words those lacking hospitals with full-time emergency medicine teams.
The Warwick study cites the Western Australia Emergency Telehealth Service (ETS, which comprises over 70 regional and remote hospital EDs as a “prominent example of this type of telehealth initiative.” The WA ETS makes specialist emergency medicine physicians available via videoconferencing to support regional hospital-based clinicians with the diagnosis and treatment of acute emergency patients. Another example in the Warwick study is the Cumbria and Lancashire Telestroke Network in Britain. This remote teleconsultation service connects 15 stroke consultants to provide ‘out-of-hours’ advice from their homes to hospital sites.
More recently, conclusive evidence about some of the above advantages has been obtained from another study at the University of Iowa’s Carver School of Medicine. The study found that telemedicine-equipped rural emergency departments provided patients with access to a clinician six minutes sooner than those in hospitals without the technology, regardless of whether or not telemedicine was used to intermediate the interactions. However, when telemedicine was used, as happened in 42% of the interactions, the door-to-provider time was shortened by nearly 15 minutes. This, according to lead author Nicholas Mohr, MD, an emergency physician and associate professor at the University, could change outcomes for patients with conditions like “severe trauma, stroke, myocardial infarction.”

Pre-ambulance triage, via teleconsultation with probable primary care patients

The second application highlighted by the Warwick researchers consists of pre-ambulance triage, via a system called ETHAN (Emergency Telehealth and Navigation). This was developed by the Houston (Texas) Fire Department in 2014, and combines teleconsultation, social services and alternative transportation. Its aim is to reduce the numbers of primary-care related patients being transported directly to the ED via fire-engine (although it could apply equally to ambulance). Apart from reducing ED patient loading, ETHAN makes substantial cost savings by eliminating unnecessary fire engine/ambulance journeys – estimated at USD 2500 per trip.
ETHAN equips EMS units with a Tablet to respond to patient initiated calls. Patients are connected via secure videoconferencing software to a hospital-based emergency physician who makes a diagnosis based on vital signs measured on scene by the field crew. After outlining treatment options, the physician then makes a final decision on whether the patient should be brought to the ED by fire engine/ambulance or via taxi, or taken by the latter to a primary care facility, or instructed on home care.
There is, however, little homogeneity in pre-ambulance triage, either in the US or elsewhere. In 2013, a systematic review of 120 publications by The Norwegian Knowledge Centre for the Health Services found that there was “a lack of scientific evidence about the effects of validated pre-hospital triage systems,” and called for further research.

Ambulance-based Triage
It has long been recognized that in-ambulance triage and care for an acute emergency patient during transportation to the ED, impact positively on patient outcomes, especially with time-critical conditions such as myocardial infarction and stroke. In several respects, Europe can be considered to be ahead of the US in this application. In Tucson (Arizona), a citywide ambulance telemedicine network, was shut down in 2011 due to budgetary problems and problems of reliability with the WiFi network.
On its part, the Warwick study reports on an ambulance-based telemedicine triage system with real-time bidirectional audio-video  communication, carried out in Brussels. In 90 per cent of cases, preliminary pre-hospital diagnosis was formulated and was in agreement with in-hospital diagnoses. Failures, as had been the case in Arizona, resulted mainly from limited mobile connectivity.

https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH192_thematic.jpg 554 800 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:29:56Emergency telemedicine

Introducing Quantra™ 2.2 Breast Density Assessment

, 26 August 2020/in Featured Articles /by 3wmedia
https://interhospi.com/wp-content/uploads/sites/3/2020/08/47339_ADS-01953-EUR-EN_Rev001_Quantra22_HR.jpg 1307 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:30:08Introducing Quantra™ 2.2 Breast Density Assessment

Nova Biomedical launches Stat EMS Basic in CE Mark countries

, 26 August 2020/in Featured Articles /by 3wmedia

Nova Biomedical has launched the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.
Specifically designed for ambulance, pre-hospital, and emergency use, Stat EMS Basic provides an important test menu and rapid results to aid with patient assessment and allow for faster, more effective emergency treatment. Stat EMS Basic also assists with rapid triage and determining the appropriate transport site for patients who have trauma, sepsis, anemia, acute coronary syndrome, or other critical illnesses.
Stat EMS Basic is a smaller, non-connectivity version of Nova’s connectivity-capable Stat EMS system with the same test menu. Stat EMS Basic combines batteryoperated StatStrip Xpress2 meters in a new, lightweight soft case that easily fits in a medic’s bag while holding all system components: meters, test strips, controls, and lancets. Test strips and controls require no refrigeration, making testing convenient and economical.
Stat EMS Basic meters use Nova’s patented, disposable test strips that provide lab-like accuracy, including the only lactate test strip cleared for fingerstick testing and the only glucose test strip proven accurate enough to have been cleared by the U.S. FDA for use with critically ill patients – and used in thousands of hospitals worldwide.
Stat EMS Basic meters are easy to use; there is no calibration or coding and the testing procedure is as simple as fingerstick glucose testing performed by people with diabetes. Tiny capillary samples eliminate the need for venipuncture, saving time and reducing costs.
For more information, visit: www.novabio.us

https://interhospi.com/wp-content/uploads/sites/3/2020/08/AD_NOVA_BIOMEDICAL.jpg 1028 682 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:29:42Nova Biomedical launches Stat EMS Basic in CE Mark countries

Hologic: The company that places special emphasis on the healthcare needs of women

, 26 August 2020/in Featured Articles /by 3wmedia

In 1985, two colleagues from American Science and Engineering, Jay Stein and David Ellenbogen, founded Hologic to commercialize a bone scanning system that employed X-ray technology. It would become the world’s first X-ray bone densitometer for evaluating osteoporosis. Over the years, Hologic has acquired complementary companies that have enabled it to become a global player in women’s health and the undisputed market leader in mammography.
International Hospital talked to Pete Valenti, Division President, Breast and Skeletal Health Solutions at Hologic to learn more about the latest developments and strategy of this innovation-driven company.

1. Hologic is most generally associated with mammography and breast disease diagnosis. However, that’s not the whole story. How would you define the current positioning of the company?
Hologic was the first company to bring digital breast tomosynthesis (DBT) to market, forging the path for how mammography exams are approached today, so it comes as no surprise that the company is most generally associated with breast cancer screening. However, as you suggest, screening is only one part of Hologic’s full story.
A global leader in women’s health, Hologic is primarily focused on improving women’s health and well-being through early detection and treatment across four divisions: Breast & Skeletal Health, Diagnostics, Gynecological Surgical Solutions and Cynosure, our medical aesthetics division. Each division is built on a foundation of the exceptional, clinically proven ability of our products to detect, diagnose and treat illnesses and other health conditions earlier and better, while also keeping in mind clinicians’ needs such as workflow efficiency.

2. Recently, Hologic has expanded its breast health product line significantly, could you briefly describe some of these innovative product launches?
We have spent the past several years thoughtfully expanding our breast health portfolio through a commitment to insight-driven innovation and strategic acquisitions that align with our mission. Now we can make a positive impact on breast health at each step of a woman’s journey – from screening to pathology.
The Trident® HD specimen radiography system and the LOCalizer™ wire-free guidance system are two products that launched in 2019 under our new breast surgery franchise.
The Trident HD system is a next-generation solution that delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies, while the LOCalizer system is designed to enable precision and ease of use for breast surgery guidance. The system’s LOCalizer tag is designed to replace traditional wire-guided methods, helping provide increased comfort and convenience for patients and their healthcare teams.
Both products have received CE Mark in Europe and reflect Hologic’s aim to benefit both patients and clinicians by arming them with accurate, efficient technology.

3. This expanded product portfolio is enabling the company to be active in breast conserving surgery as well as pathology. Do you see these segments as a major growth opportunity?
I absolutely see breast conserving surgery and pathology as growth opportunities for Hologic; and, as touched upon earlier, I believe our expansion into these parts of the breast care continuum is also about making as much of a positive impact as possible for patients and clinicians throughout the entire pathway of care.
4. There have also been some strategic acquisitions lately, for example with the LOCalizer. Is this a scenario that might be repeated in the near future?
At Hologic, we are in a fortunate position where we are able to both innovate healthcare solutions from within and make strategic acquisitions from external sources. As opportunities arise, we are always willing to examine how we can continue to impact patients and clinicians in a positive way through new and consistently high-quality technology. 

5. What do you see as the next step for Hologic?
Hologic will continue to work to bring to market crucial healthcare solutions that address both patients’ and clinicians’ needs by taking into consideration all factors, from accuracy and workflow efficiency, to the patient experience and beyond. It is approaching innovation with this holistic view that sets Hologic apart as an industry leader, and by bringing this mindset into new areas of the healthcare continuum like breast conservation surgery, I believe Hologic will make an even greater positive impact on the lives of women across the globe.
I think we’ll also see great evolution in our technology and approaches to risk stratification as we continue to explore how to best leverage the benefits of artificial intelligence to support clinicians and the important work they are doing.

www.hologic.com
https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH196_Hologic_Q_A_article_valenti2.jpg 800 800 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:29:51Hologic: The company that places special emphasis on the healthcare needs of women

IHF: Traceability and barcoding

, 26 August 2020/in Featured Articles /by 3wmedia
https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH187_IHF_page1.jpg 1500 1060 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:29:59IHF: Traceability and barcoding

CMEF Spring 2020

, 26 August 2020/in Featured Articles /by 3wmedia
https://interhospi.com/wp-content/uploads/sites/3/2020/08/CMEF_Spring_2020.jpg 1396 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:29:46CMEF Spring 2020

KIMEX 2020, 19-22 March 2020, COEX, Seoul

, 26 August 2020/in Featured Articles /by 3wmedia
https://interhospi.com/wp-content/uploads/sites/3/2020/08/KIMES_2020_IHE_Junior_revised.jpg 1457 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:29:54KIMEX 2020, 19-22 March 2020, COEX, Seoul

IHF: University Hospital Governance

, 26 August 2020/in Featured Articles /by 3wmedia
https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH176_IHF_page1.jpg 1415 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:30:02IHF: University Hospital Governance

Medica Fair Asia 2020

, 26 August 2020/in Featured Articles /by 3wmedia
https://interhospi.com/wp-content/uploads/sites/3/2020/08/MFA2020_EPAD_92X178mm_FA_IHE.jpg 1877 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:29:48Medica Fair Asia 2020

Fujifilm Medical Systems Europe highlights artificial intelligence initiative at ECR 2019 and celebrates 20 years of its Synapse PACS

, 26 August 2020/in Featured Articles /by 3wmedia

This year at the European Congress of Radiology (ECR), Fujifilm displays its evolving portfolio of medical informatics and Enterprise Imaging innovations, presenting REiLI, its Artificial Intelligence (AI) technology initiative, and enhanced Synapse functions with SYNAPSE 3D CONSOLE MODE.

Fujifilm Medical Systems Europe will celebrate SYNAPSE’S 20-year anniversary and will present, REiLI the company’s global Medical Imaging and Informatics Artificial Intelligence (AI) technology initiative at the European Congress of Radiology (ECR) annual meeting to be held from February 27th to March 3rd, 2019 at the Austria Congress Center in Vienna, Austria.

Under the REiLI brand, Fujifilm is developing AI technologies that strongly support diagnostic imaging workflow, leveraging the combination of deep learning in its AI technology with the Company’s image processing heritage. Fujifilm’s artificial intelligence software is a work in progress and is not commercially available in Europe.
Applications currently in development include, but are not limited to: Region Recognition, an AI technology to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions; Computer Aided Detection, an AI technology to reduce the time of image interpretation and support radiologists’ clinical decision making; Workflow Support, using AI technology to realize optimal study prioritization, alert communications of AI findings, and report population automation. At Fujifilm’s in-booth AI Center, it will be possible to see live demonstrations of AI delivering enhanced workflows.

SYNAPSE 3D CONSOLE MODE
is the powerful native Advanced Visualization workflow in Synapse PACS. Synapse 3D is designed to enhance visualization features in Synapse 5. It offers advanced 3D rendering in the Synapse PACS Viewer to perform fast and accurate extractions, stenosis measurements, brain perfusion CT, MRI, and more.

The Fujifilm Healthcare IT platform showcased at ECR includes also the comprehensive medical informatics and enterprise-imaging portfolio:

SYNAPSE 5
is our next generation PACS, Synapse is one of the fastest medical imaging solutions in the industry, offering sub second delivery of extremely large datasets. Its underlying architecture promotes significantly less bandwidth consumption and tighter security.

SYNAPSE VNA is the most secure, comprehensive application for ingesting, storing and providing access to the complete imaging record. It securely integrates more specialties, more devices, and more data than any other VNA.

SYNAPSE MOBILITY
Enterprise Viewer uses the latest server-side rendering technology to stream imaging securely and quickly to any authorized user. It can be used within applications, directly from the EHR, or on our mobile device apps. Both within and outside of the Enterprise, giving access to imaging immediately and helping clinicians making the most informed and accurate decisions.

SYNAPSE 3D
is an enterprise-wide solution for quickly accessing multiple Advanced Visualization processing tools (in excess of 50 modules). Designed for use across multiple specialties including radiology, cardiology, surgery and more. Full integration with Synapse PACS means one-click extremely fast image processing from any Synapse client.

SYNAPSE CWM
, Clinical Workflow Manager, is the most advanced Radiology Information System on the market today. It continues to evolve to support the unique imaging and information needs in today’s radiology department. One platform can support acute care facilities, imaging centres, and radiology practices providing distributed diagnosis.

SYNCRO-DOSE is the Radiation Dose Index Monitoring system, compliant with the Directive 2013/59 / EURATOM of the European Union. Syncro-Dose is a comprehensive system for monitoring and managing patient radiation exposure at enterprise level across different imaging modalities and hospital facilities.

THE 20-YEAR ANNIVERSARY OF SYNAPSE: THE WORLD’S FIRST WEB- BASED PACS

In 1983, Fujifilm launched Fuji Computed Radiography (FCR), becoming the first company in the world to offer a digital X-ray diagnostic imaging system. Medical professionals quickly learned the merits of digital diagnostic images, including ease of storage and processing. They found that images from a variety of tests and procedures could be shared within and among facilities, and the images could even be used for remote diagnosis and consultation. Recognizing this trend, Fujifilm saw the opportunity to leverage the technologies it had developed for FCR and contribute to the evolution of connectivity within and among medical facilities. What made Fujifilm’s SYNAPSE concept different was that it used the emerging Internet and web technologies instead of private networks. It was, in essence, a Web-based PACS: the first in the world.
Offering outstanding medical connectivity based on the convenient and efficient sharing of information, SYNAPSE made possible initial diagnosis at a local clinic, followed by more complete testing and treatment at a larger medical facility, in turn followed by periodic monitoring at the original local clinic. SYNAPSE’s rapid rate of adoption was due in large part to its capability, to contribute significantly to the quality of medical care, including support for the important objective of informed consent. Nowadays 5000 Synapse PACS systems are installed in healthcare facilities around the world, earning the largest market share worldwide (estimation based on a set of data from multiple market research studies), and last September “SYNAPSE 3D” (also known as Synapse Vincent in some global markets) a 3D image analysis system, won the Red Dot Award: Communication Design 2018 – the prestigious international design award in recognition of superior design, outstanding performance, and excellent operability.

www.fujifilm.euwww.fujifilmholdings.com
https://interhospi.com/wp-content/uploads/sites/3/2020/08/IH189_Fujifilm_REiLI.jpg 800 615 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:16:482021-01-08 12:29:56Fujifilm Medical Systems Europe highlights artificial intelligence initiative at ECR 2019 and celebrates 20 years of its Synapse PACS
Page 99 of 102«‹979899100101›»

Latest issue of International Hospital

April 2024

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

27 June 2025

GE HealthCare advances cardiac PET diagnostics with Flyrcado launch

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription